Clinical Trial Update: Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the safety of intravenous immunoglobulin (IVIG) after portoenterostomy in infants with biliary atresia has completed with posted resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Atresia

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Biliary Atresia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-05-11